Skip to content
Screener

Teladoc Health TDOC Q3 2026 earnings

Reported October 28, 2026 · After market close

Revenue$605.1MBeat by $17.0M
EPS-$0.15Beat by $0.07
Revenue estimate$588.1M
EPS estimate-$0.22
“We delivered third quarter results near the upper end of our guidance range for consolidated revenue and above our range for consolidated adjusted EBITDA, reflecting solid execution across our two segments. Within the Integrated Care segment, we continue to advance our innovation agenda, including the implementation of Teladoc One with our early launch partners, while also expanding our capabilities through initiatives such as hybrid care and AI-enabled solutions. In the BetterHelp segment, insurance revenue exceeded our expectations, and we are making encouraging progress expanding provider capacity and scaling access to covered services. While there is more work ahead, we remain focused on disciplined execution against our strategic priorities. The actions we are taking are showing traction, and we believe will position us well for the opportunities ahead.”
Chuck Divita

Next report

Date not yet announced

Financials

Q3 2026

Income statement

See full
Revenue$605.1M-3.4%
Gross profit$414.8M-5.6%
Operating income-$28.1M+45.9%
Net income-$26.9M+45.6%
EPS (diluted)-$0.15+46.4%

Balance sheet

See full
Cash & equivalents$849.9M+17.0%
Total debt$1.0B+2,055%
Total equity$1.3B-7.0%
Total assets$2.8B-3.6%

Cash flow

See full
Operating cash flow$106.5M+7.2%
CapEx$1.2M-46.8%
Free cash flow$105.2M+8.5%

Valuation & ratios

Valuation

as of 10/30/26
See full
Market cap$1.59B+2.7%
Enterprise value$1.78B+104%
P/S0.6×0.0×

Profitability

See full
Gross margin68.6%-1.2pp
Operating margin-6.6%-1.9pp
Net margin-6.3%-1.4pp
FCF margin10.6%-0.5pp

Returns & leverage

See full
Return on equity-11.5%-2.3pp
Debt / equity0.8×+0.8×
Current ratio0.9×-1.8×

Segments

By segment

See full
Integrated Care$398.5M+2.3%
BetterHelp$206.6M-12.8%

By product

See full
Access Fees$466.7M-10.4%
Other$138.4M+31.1%

FAQ

When did Teladoc Health report Q3 2026 earnings?
Teladoc Health (TDOC) reported Q3 2026 earnings on October 28, 2026 after market close.
What were Teladoc Health's Q3 2026 revenue and EPS?
Teladoc Health reported revenue of $605.1M and eps of $-0.15 for Q3 2026.
Did Teladoc Health beat estimates in Q3 2026?
Revenue beat the consensus estimate of $588.1M by $17.0M. EPS beat the consensus estimate of $-0.22 by $0.07.
How did Teladoc Health's Q3 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 3.4% from $626.4M a year earlier and eps grew 28.6% from $-0.21.
Where can I find Teladoc Health's Q3 2026 SEC filings?
You can read the 8-K earnings release (0001477449-26-000050) and the 10-Q periodic report (0001477449-26-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.